Literature DB >> 11387509

The utility of health states after stroke: a systematic review of the literature.

P N Post1, A M Stiggelbout, P P Wakker.   

Abstract

BACKGROUND: To perform decision analyses that include stroke as one of the possible health states, the utilities of stroke states must be determined. We reviewed the literature to obtain estimates of the utility of stroke and explored the impact of the study population and the elicitation method. SUMMARY OF REVIEW: We searched various databases for articles reporting empirical assessment of utilities. Mean utilities of major stroke (Rankin Scale 4 to 5) and minor stroke (Rankin Scale 2 to 3) were calculated, stratified by study population and elicitation method. Additionally, the modified Rankin Scale was mapped onto the EuroQol classification system. Utilities were obtained from 23 articles. Patients at risk for stroke assigned utilities of 0.26 and 0.55 to major and minor stroke, respectively. Stroke survivors assigned higher utilities to both major (0.41) and minor stroke (0.72). The EuroQol completed by stroke survivors revealed a utility of 0.32 and 0.71 for major and minor stroke, respectively. Utilities elicited by the Standard Gamble were generally higher, while those obtained by the Visual Analogue Scale were lower than the Time Trade Off values. Remaining variation between utilities may be caused by differences in definitions of the health states. The mapped EuroQol indicated a utility of 0.64 for minor stroke and a value just below zero for major stroke.
CONCLUSIONS: For minor stroke, a utility between 0.50 and 0.70 seems to be reasonable for both decision analyses and cost-effectiveness studies. The utility of major stroke may range between 0 and 0.30 and may possibly be negative.

Entities:  

Mesh:

Year:  2001        PMID: 11387509     DOI: 10.1161/01.str.32.6.1425

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  52 in total

1.  Cost-effectiveness of multimodal CT for evaluating acute stroke.

Authors:  Kate C Young; Curtis G Benesch; Babak S Jahromi
Journal:  Neurology       Date:  2010-10-06       Impact factor: 9.910

2.  Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage.

Authors:  J Ivanidze; R A Charalel; I Shuryak; D Brenner; A Pandya; O N Kallas; K Kesavabhotla; A Z Segal; M S Simon; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-12       Impact factor: 3.825

3.  Patient-reported health preferences of anticoagulant-related outcomes.

Authors:  Ye Wang; Feng Xie; Ming Chai Kong; Lai Heng Lee; Heng Joo Ng; Yu Ko
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

4.  Comment on the value of vision by Knauer et al..

Authors:  George L Spaeth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-17       Impact factor: 3.117

5.  Preoperative risk assessment for bleeding and thromboembolism.

Authors:  Donald M Arnold; Julia Anderson; Clive Kearon
Journal:  BMJ       Date:  2009-09-03

6.  Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.

Authors:  Sutat Kantito; Surasak Saokaew; Sukit Yamwong; Prin Vathesatogkit; Wisuit Katekao; Piyamitr Sritara; Nathorn Chaiyakunapruk
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

7.  Preferences and Utilities for Health States after Treatment of Olfactory Groove Meningioma: Endoscopic versus Open.

Authors:  Christopher M Yao; Alyssa Kahane; Eric Monteiro; Fred Gentili; Gelareh Zadeh; John R de Almeida
Journal:  J Neurol Surg B Skull Base       Date:  2017-02-17

8.  Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  P C Sanelli; A Pandya; A Z Segal; A Gupta; S Hurtado-Rua; J Ivanidze; K Kesavabhotla; D Mir; A I Mushlin; M G M Hunink
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

9.  Assessment of post-stroke quality of life in cost-effectiveness studies: the usefulness of the Barthel Index and the EuroQoL-5D.

Authors:  N J A van Exel; W J M Scholte op Reimer; M A Koopmanschap
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

10.  Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.

Authors:  T Enden; S Resch; C White; H S Wik; N E Kløw; P M Sandset
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.